Neurizon Therapeutics (FRA:ECQ0) FCF Yield % : -17.71 (As of Apr. 21, 2025)

Neurizon Therapeutics FCF Yield % Chart

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
FCF Yield %	Get a 7-Day Free Trial															-7.95	-0.89	-0.25	-16.23	-14.34

Competitive Comparison of Neurizon Therapeutics's FCF Yield %

For the Biotechnology subindustry, Neurizon Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurizon Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's FCF Yield % falls into.

Neurizon Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Neurizon Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2005 is calculated as

Neurizon Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurizon Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Neurizon Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description